A viscoelastic solution including a polysaccharide selected from hyaluronic acid, chondroitin sulfate, keratan, keratan sulfate, dermatan sulfate, heparin, heparan sulfate, chitosan, xanthans, alginates and carrageenans, or one of the salts thereof; and an antifibrinolytic agent selected from tranexamic acid, epsilon-aminocaproic acid, protamine and desmopressin; and its use in rheumatology.